Last 12 months
- May 2022 (0)
- April 2022 (0)
- March 2022 (2)
- February 2022 (3)
- January 2022 (1)
- December 2021 (3)
- November 2021 (1)
- October 2021 (2)
- September 2021 (1)
- August 2021 (1)
- July 2021 (2)
- June 2021 (1)
- Show All
- Infection (1)
- Visiting Speaker Program (4)
- Immunology (97)
- Closing Soon (4)
- Journals (18)
- Special Interest Groups (3)
- Immunology & Cell Biology (22)
- Women's Initiative (10)
- ASI Awards (55)
- Clinical & Translational Immunology (9)
- ASI (85)
- Day of Immunology (17)
- Competition (8)
- ASI Membership (24)
- Vaccines (32)
- Event/Meeting (39)
- Show All
Friday October 22, 2021
Introducing the new
ASI AbbVie New Horizons Research Award
Application round: October 22nd - November 1st 2021
With much excitement, we announce a brand new award in partnership with AbbVie.
We are now accepting applications to the
ASI AbbVie New Horizons Research Award,
so be sure to apply if you are eligible.
AbbVie is a global biopharmaceutical company committed to developing innovative therapies for some of the world’s most complex conditions. In Australia, we employ more than 450 people with our therapies currently benefiting more than 30,000 Australians across several therapeutic areas: Immunology, Oncology, Virology, Neuroscience, Eye Care and Aesthetics.
AbbVie is committed to moving science forward to further develop medicines that can change the lives of people living with immune-mediated conditions such as Autoimmunity and Inflammation.
Within these therapeutic areas, AbbVie has identified gaps in immunology research, particularly in the areas of new biological pathways, druggable targets and biomarkers, leading to paucity of innovation in therapeutics and precision medicine.
To encourage investment in emerging areas, AbbVie will sponsor a research award that recognises an exceptional Australian or New Zealand Researcher who is leading in future-focused research that has potential to advance scientific exploration in emerging areas.
In its inaugural year, ASI and AbbVie have partnered to launch the ASI AbbVie New Horizons Research Award, initially focussing on Immunology.
To support a mid career research Immunologist (10-20 years post-doctoral) with potential to advance research in emerging areas such as new biological pathways, druggable targets and biomarkers, within the fields of Autoimmunity, Inflammation, and other Immune-mediated Diseases (excluding Infectious Diseases).
The key objective of the ASI AbbVie New Horizons Research Award is to invigorate basic, translational or applied research in these areas of strategic importance.
Mid-career researchers with 10-20 years post-doctoral research experience (counted at application deadline). Career disruptions (such as maternity leave) may be taken into account. Please provide details if you feel that you are eligible to apply.
Applicants are strongly encouraged to be Ordinary members of ASI at the time of application.
A single grant of AUD $80 000 for 1 year will be awarded to an individual via their research institute or affiliated university.
For more information on how to apply, assessment criteria, and terms and conditions, please click the green button below.